POCUS_ACQ: Prospective Acquisition of Cardiac Ultrasound Images at the Point of Care

Sponsor
Aisap LTD (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05631977
Collaborator
(none)
300
1
2.2
134.3

Study Details

Study Description

Brief Summary

The present study is a preparatory step towards a multi-reader multi case (MRMC) randomized fully crossed study. As POCUS images are frequently not stored and not methodically acquired using a standardized image acquisition protocol this study will collect cardiac POCUS images in a prespecified manner.

Condition or Disease Intervention/Treatment Phase
  • Other: Point of care ultrasound cardiac examination

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Acquisition of Cardiac Ultrasound Images at the Point of Care
Actual Study Start Date :
Jan 23, 2023
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
POCUS acquisition

Prospective noninterventional single arm study collection of cardiac POCUS examination according to prespecified acquisition protocol. Alongside POCUS images the study will also collect demographic and clinical information from the study participants and some information from the healthcare personal performing the POCUS exam (experience in US image acquisition, physician specialty or sonographer). Patient management will not be impacted, and usual care will follow the regular practices at the study site.

Other: Point of care ultrasound cardiac examination
The study intervention consists of a POCUS cardiac examination by site approved personal using an FDA cleared US scanner. Usual care of study participants will not be impacted.

Outcome Measures

Primary Outcome Measures

  1. POCUS QUALITY [1 month]

    Primary endpoint: Percent of POCUS exams that attain the pre-specified POCUS image quality threshold (quality standard)

Secondary Outcome Measures

  1. Subgroup analysis [1 month]

    Analysis of primary endpoint (POCUS exam quality) by the prespecified subgroups of age (above or below 65), gender, BMI group (below or above 25) and US device manufacturer.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

  1. Provision of signed and dated informed consent form

  2. Stated willingness to comply with all study procedures and availability for the duration of the study

  3. Male or female, aged 21 or more

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in this study:

  1. Unstable clinical condition according to PI clinical judgment

  2. Presence of prosthetic cardiac valve at any position and any type

  3. Pregnancy or lactation

  4. Contact isolation due to infections disease

  5. Presence of left ventricular assist device (LVAD)

  6. Know existence of congenital heart disease

  7. Prosthetic cardiac valve, any

  8. BMI 40 or greater

  9. Clinical conditions that do not permit a POCUS study according to the judgment of the investigators or treating physicians

  10. History of lung resection

  11. Known poor cardiac US image quality based on prior echo exams

  12. Mechanical ventilation, or other situations where the required ultrasound views cannot be adequately obtained

  13. Clinical instability or critical subject condition or any condition the study PI judges that the POCUS exam could adversely affect the participant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sheba Medical Center Ramat Gan Israel

Sponsors and Collaborators

  • Aisap LTD

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aisap LTD
ClinicalTrials.gov Identifier:
NCT05631977
Other Study ID Numbers:
  • POC1
First Posted:
Nov 30, 2022
Last Update Posted:
Feb 2, 2023
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aisap LTD
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 2, 2023